Hammersmith gets local connection rule
London local authority restricts social housing.
Yet another London borough authority has moved to stem the flow of people applying for social housing, with only those with a five-year connection to the local area permitted access to subsidised homes.
According to Hammersmith and Fulham council, new sanctions will be put into place in order to prioritise "local homes for local people", with a residency test being introduced as part of the application process.
The district follows an example set by Kensington and Chelsea, which last month stated that only vulnerable parties from local areas will be offered social tenancies and terminated lifetime contracts.
Prime minister David Cameron last week advocated the changes and told local authorities all over the country that they should be implementing the same measures in an attempt to control social housing waiting lists, which have been spinning out of control.
Councillor Andrew Johnson, the council's cabinet member for housing, said: “It cannot be fair for decent, honest people to sit on a council housing register for years and years and then see their housing dreams turn to dust when a new migrant, or someone from elsewhere in the country overtakes them in the queue."
The council stated that one person had been on the list for social housing for 36 years, while last year just 470 new lettings were made. It is hoped that adjustments to housing policy will avoid situations like these.
"Hammersmith and Fulham Council is … changing the rules so that local people with a five year connection to the borough come first," Mr Johnson concluded.
The local authority is currently constructing homes to add to its extensive portfolio of social housing, having started up its own company last year to deal with an influx of applications for affordable housing.
It hopes to have completed 500 low-cost units within the next ten years.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...